Direct Components

Direct Components is a private U.S. company developing and selling applied life science and biomechanical products spanning wound management, hemorrhage control, and infection-prevention use cases. Its healthcare offering appears centered on Samaritan, a multi-focal polymer marketed for IV and port access infection prevention, wound applications, and certain cosmetic procedure applications. The company also describes itself more broadly as a maker of innovative bio-mechanical products intended to improve safety and human performance, while operating across non-health verticals such as target acquisition and portable power. Based on available public information, Direct Components is not a therapeutics developer but a small commercial-stage medical products manufacturer with a mixed portfolio. Publicly available evidence for a traditional drug pipeline, molecular targets, or clinical-stage development programs is limited.